HLA-C and cancer: The results showed that TUBA1C had a positive correlation with most MHC-related genes in THCA, BLCA, and BRCA, and the TAP1 gene was positively correlated with TUBA1C in almost all cancer types, suggesting that TAP1 is a potential immunotherapeutic target.